BlackRock, Inc. - Mar 31, 2025 Form SCHEDULE 13G/A Schedule Report for Denali Therapeutics Inc. (DNLI)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Denali Therapeutics Inc. Common Stock
Symbol: DNLI
Shares outstanding: 146M shares
Disclosed Ownership: 10.5M shares
Ownership: 7.2%
Form type: SCHEDULE 13G/A
Date filed: 4/17/2025, 03:05 PM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	7.2%	10.5M	10.3M	0	Spencer Fleming	Managing Director